Public Company News
Inspiring Women's Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System
SHENZHEN, China, June 8, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global
leading developer and provider of medical devices and solutions, has introduced
theNuewa I9
iHuman Inc. Announces First Quarter 2021 Unaudited Financial Results
BEIJING, June 8, 2021 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("Human" or the "Company"), a leading childhood edutainment company inChina, today announced its unaudited financial results for the first quarter ended March 31, 2021. First Quarter 2021 Highlights * Total revenues were RMB226.7...
Ying Hai Announces Possible Acquisition of a Zhuhai Travel Company
HONG KONG, June 8, 2021 /PRNewswire/ -- Ying Hai Group Holdings Company Limited ("the Company" or "Ying Hai Group", together with its subsidiaries, the "Group", HKSE stock code: 8668) is pleased to announce that, the Group will acquire Zhuhai Huanya International Tourism Co., Ltd. ("Target Comp...
A Snapshot of SID Display Week 2021: BOE leads the way in display industry, bringing momentum to "China's moment"
BEIJING, June 7, 2021 /PRNewswire/ -- The below news release is from DINGKEJI.COM about BOE Technology Group: In order to move forward, you have to leave where you are now -- this is an inspirational quote from bestsellerUnder the Tuscan Sun. With the rapid advancement of display technology, t...
Pearl Abyss Releases BUGATTI Collaboration for Black Desert
SEOUL, South Korea, June 8, 2021 /PRNewswire/ -- Pearl Abyss today announced a
collaboration with BUGATTI. The prestigious French brand will appear across the
world ofBlack Desert across all platforms. Adventurers can now enjoy this
collaboration through special quests and branded items.
Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress
SAN FRANCISCO and SUZHOU, China, June 8, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL
SUZHOU, China, and ROCKVILLE, MD, June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released updated results from the first...
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs
SUZHOU, China, and ROCKVILLE, Md., June 8, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today presented in an oral presentation at t...
TIAN RUIXIANG Holdings Ltd Announces Initial Closing of Follow-on Public Offering
BEIJING, June 07, 2021 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), aChina-based insurance broker, announced today the initial closing of its previously announced best-effort follow-on public offering for the sale of up to 4,800,000 units offered by the Company at a ...
Senmiao Technology Announces Over 2.1 Million Completed Rides on its Ride-Hailing Platform in May 2021
CHENGDU, China, June 7, 2021 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao") (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry inChina as well as an operator of its own online ride-hailing platform, today announced operating metrics for its propr...
ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico
RARITAN, N.J., June 7, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care ...
Elekta's new strategy to focus on growth and access to radiation therapy
STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO,Gustaf Salford, and members from his executive management team introduced the company's mid-term strategy, called Access 2025. The strategy reflects the work the company will continue to do to pursue the visi...
Huya Inc. Joins the Coalition to End Wildlife Trafficking Online, Leveraging Power of Livestreaming for Public Welfare
GUANGZHOU, China, June 7, 2021 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading Chinese livestreaming platform, has joined the Coalition to End Wildlife Trafficking Online (the "Coalition") for World Environment Day which fell onJune 5. It hopes to clean up further th...
Ambow Education Inks Strategic Cooperation Agreement with Kylinsoft
BEIJING, June 7, 2021 /PRNewswire/ -- Ambow Education Holding Ltd. ("Ambow" or "the Company") (NYSE American: AMBO),China's leading provider of educational and career enhancement services, today announced it has entered into a cooperation agreement ("Cooperation Agreement") with Kylinsoft, a lead...
Study of Paxalisib in Primary CNS Lymphoma at Dana-Farber Cancer Institute Enrols First Patient
SYDNEY, June 7, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that a phase II study of Kazia's investigational new drug, paxalisib, in primary CNS lymphoma has been initiated at Dana-Farber Cancer Ins...
RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study
The global Phase 2/3 study of orally-administered opaganib for the treatment of severe COVID-19 enrolled a total of 475 patients, more than the planned 464 Opaganib is uniquely positioned as a leading novel, dual-action, investigational COVID-19 oral pill Blinded blended mortality rates encourag...
Tantech Announces Closing of US$7.0 Million Offering
LISHUI, China, June 7, 2021 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"), a clean energy company inChina, today announced that it closed a previously announced private placement transaction (the "Private Placement"), raising approximatelyUS$7.0 million in gross...
Clarivate Forecasts Nearly 70% of North American, European and Asia Pacific Adult Populations Will Be Vaccinated for COVID-19 by September 2021
New report analyzes how the emergence and increased availability of vaccines will impact the recovery of healthcare markets across the globe LONDON, June 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of inn...
Elekta and Philips deepen strategic partnership in precise and individualized oncology care
STOCKHOLM and AMSTERDAM, June 7, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) and Royal Philips (NYSE: PHG, AEX: PHIA) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions. The extended collab...
WeChat Pay HK and Visa Collaborate to Support Disbursement of Hong Kong SAR Government's Consumption Voucher Scheme
* Collaboration aims to boost economic recovery and digital transformation of small and medium-sized businesses inHong Kong * WeChat Pay HK to waive service fee transactions for "WeChat Pay HK Checkout" merchants during the scheme period; Visa to invest in driving consumptionvoucher usage HON...
Week's Top Stories
Most Reposted
Visa Destinations Launches in Asia Pacific as Regional Travel Remains Resilient
[Picked up by 329 media titles]
2026-05-05 10:01Agoda Makes it Easier for Travelers to See Relevant Photos in Reviews
[Picked up by 310 media titles]
2026-05-06 12:00AVPN AI Opportunity Fund Expands to Build AI-Ready Generations Across Asia by Empowering Educators and Youth Across Asia-Pacific
[Picked up by 296 media titles]
2026-05-05 09:00Colebrook Bosson Saunders Expands Flo X Multi Compatibility for Curved Ultrawide Monitors
[Picked up by 288 media titles]
2026-05-05 11:00REVIVING HERITAGE: REBIRTH OF A LEGACY
[Picked up by 282 media titles]
2026-04-30 16:24